Nexstim Receives System Orders from Existing Hospital Customers in Finland

nexstim receives system orders from existing hospital customers in finland

Sumary of Nexstim Receives System Orders from Existing Hospital Customers in Finland:

  • The benefit for our customers is significant as well: our unique SmartFocus® TMS technology, that is used in both our NBS and NBT® systems, allows for both diagnostics and treatment of challenging brain diseases and disorders, offering patients a chance for a better quality of life.
  • comAbout Nexstim PlcNexstim is a Finnish, globally operating medical technology company.
  • Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.
  • Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®.
  • It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
  • Story continuesSmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.